Cost-effective method of serotyping Streptococcus pneumoniae using staphylococcal co-agglutination

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Streptococcus pneumoniae serotype prevalence varies geographically, necessitating regional typing for effective polyvalent vaccine development.
• High costs associated with traditional antisera present a barrier to undertaking essential serotype prevalence studies.
• Accurate serotyping is vital for guiding vaccine strategies and preventing invasive pneumococcal infections.

Purpose of the Study:

• To evaluate the co-agglutination method as a simple, rapid, and economical alternative for typing Streptococcus pneumoniae serotypes.
• To determine the serotype prevalence of clinical isolates from Pondicherry and surrounding Tamil Nadu.
• To compare the efficacy of co-agglutination with the standard quellung reaction for serotyping.

Main Methods:

• Clinical isolates of S. pneumoniae were serotyped using Staphylococcus aureus Cowan I strain coated with antisera.
• The co-agglutination results were compared against the standard quellung reaction for validation.
• A commercially available Pneumotest kit served as the source for type-specific antisera.

Main Results:

• The co-agglutination method demonstrated 100% correlation with the standard quellung reaction.
• Serotype 1 was identified as the predominant isolate (20.1%) in the studied region.
• Non-vaccine types accounted for 13% of isolates, with serotypes 6, 5, 19, 23, and 12 also being prevalent.

Conclusions:

• Co-agglutination is a validated, simple, rapid, and economical technique for S. pneumoniae serotyping.
• This method facilitates accurate determination of serotype prevalence, aiding in the development of targeted pneumococcal vaccines.
• The reagent has a shelf life of six months at 4°C, making it practical for widespread use.